PDB Short entry for 4UDC HEADER SIGNALING PROTEIN 09-DEC-14 4UDC TITLE GR IN COMPLEX WITH DEXAMETHASONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOCORTICOID RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, UNP RESIDUES 500-777; COMPND 5 SYNONYM: GR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RESIDUES 740-753; COMPND 12 SYNONYM: NCOA-2, CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 75, BHLHE75, COMPND 13 TRANSCRIPTIONAL INTERMEDIARY FACTOR 2, HTIF2, NCOA2; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606 KEYWDS SIGNALING PROTEIN, NUCLEAR HORMONE RECEPTOR, LIGAND COMPLEX, PEPTIDE KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.EDMAN,A.HOGNER,A.HUSSEIN,M.BJURSELL,A.AAGAARD,S.BACKSTROM,C.BODIN, AUTHOR 2 L.WISSLER,T.JELLESMARK-JENSEN,A.CAVALLIN,U.KARLSSON,E.NILSSON, AUTHOR 3 D.LECINA,R.TAKAHASHI,C.GREBNER,M.LEPISTO,V.GUALLAR REVDAT 5 20-DEC-23 4UDC 1 REMARK REVDAT 4 03-APR-19 4UDC 1 SOURCE REVDAT 3 16-DEC-15 4UDC 1 JRNL REVDAT 2 09-DEC-15 4UDC 1 JRNL REVDAT 1 25-NOV-15 4UDC 0 JRNL AUTH K.EDMAN,A.HOSSEINI,M.K.BJURSELL,A.AAGAARD,L.WISSLER, JRNL AUTH 2 A.GUNNARSSON,T.KAMINSKI,C.KOHLER,S.BACKSTROM,T.J.JENSEN, JRNL AUTH 3 A.CAVALLIN,U.KARLSSON,E.NILSSON,D.LECINA,R.TAKAHASHI, JRNL AUTH 4 C.GREBNER,S.GESCHWINDNER,M.LEPISTO,A.C.HOGNER,V.GUALLAR JRNL TITL LIGAND BINDING MECHANISM IN STEROID RECEPTORS: FROM JRNL TITL 2 CONSERVED PLASTICITY TO DIFFERENTIAL EVOLUTIONARY JRNL TITL 3 CONSTRAINTS. JRNL REF STRUCTURE V. 23 2280 2015 JRNL REFN ISSN 0969-2126 JRNL PMID 26602186 JRNL DOI 10.1016/J.STR.2015.09.012 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 15559 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 778 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.67 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.43 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2754 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3015 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2602 REMARK 3 BIN R VALUE (WORKING SET) : 0.2986 REMARK 3 BIN FREE R VALUE : 0.3501 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.52 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 152 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2133 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 83 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.81 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.83030 REMARK 3 B22 (A**2) : -8.83030 REMARK 3 B33 (A**2) : 17.66060 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.338 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.322 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.242 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.312 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.241 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.914 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.899 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2247 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3058 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 807 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 58 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 307 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2247 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 298 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2705 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.12 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.51 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.07 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4UDC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1290062338. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUL-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.94 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15574 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 31.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.55000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1M2Z REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG8000, 10% ETHYLENE GLYCOL, 0.1 REMARK 280 M HEPES PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.60667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 35.30333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 35.30333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 70.60667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 498 REMARK 465 SER A 499 REMARK 465 ILE A 500 REMARK 465 GLN A 501 REMARK 465 GLN A 502 REMARK 465 ALA A 503 REMARK 465 THR A 504 REMARK 465 THR A 505 REMARK 465 GLY A 506 REMARK 465 VAL A 507 REMARK 465 SER A 508 REMARK 465 GLN A 509 REMARK 465 GLU A 510 REMARK 465 THR A 511 REMARK 465 SER A 512 REMARK 465 GLU A 513 REMARK 465 ASN A 514 REMARK 465 PRO A 515 REMARK 465 GLY A 516 REMARK 465 ASP A 517 REMARK 465 LYS A 518 REMARK 465 THR A 519 REMARK 465 ILE A 520 REMARK 465 VAL A 521 REMARK 465 PRO A 522 REMARK 465 ALA A 523 REMARK 465 THR A 524 REMARK 465 LEU A 525 REMARK 465 PRO A 526 REMARK 465 GLN A 527 REMARK 465 LEU A 528 REMARK 465 LYS A 777 REMARK 465 LYS B 740 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 638 -1.86 69.34 REMARK 500 ARG A 704 72.93 -113.46 REMARK 500 GLU A 705 106.07 -53.64 REMARK 500 ASN A 707 133.23 9.90 REMARK 500 SER A 708 -39.19 -130.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CPS A 1777 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CPS A 1777 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DEX A 1778 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UDA RELATED DB: PDB REMARK 900 MR IN COMPLEX WITH DEXAMETHASONE REMARK 900 RELATED ID: 4UDB RELATED DB: PDB REMARK 900 MR IN COMPLEX WITH DESISOBUTYRYLCICLESONIDE REMARK 900 RELATED ID: 4UDD RELATED DB: PDB REMARK 900 GR IN COMPLEX WITH DESISOBUTYRYLCICLESONIDE DBREF 4UDC A 500 777 UNP P04150 GCR_HUMAN 500 777 DBREF 4UDC B 740 753 UNP Q15596 NCOA2_HUMAN 740 753 SEQADV 4UDC GLY A 498 UNP P04150 EXPRESSION TAG SEQADV 4UDC SER A 499 UNP P04150 EXPRESSION TAG SEQADV 4UDC ASP A 517 UNP P04150 ASN 517 ENGINEERED MUTATION SEQADV 4UDC SER A 602 UNP P04150 PHE 602 ENGINEERED MUTATION SEQADV 4UDC ASP A 638 UNP P04150 CYS 638 ENGINEERED MUTATION SEQRES 1 A 280 GLY SER ILE GLN GLN ALA THR THR GLY VAL SER GLN GLU SEQRES 2 A 280 THR SER GLU ASN PRO GLY ASP LYS THR ILE VAL PRO ALA SEQRES 3 A 280 THR LEU PRO GLN LEU THR PRO THR LEU VAL SER LEU LEU SEQRES 4 A 280 GLU VAL ILE GLU PRO GLU VAL LEU TYR ALA GLY TYR ASP SEQRES 5 A 280 SER SER VAL PRO ASP SER THR TRP ARG ILE MET THR THR SEQRES 6 A 280 LEU ASN MET LEU GLY GLY ARG GLN VAL ILE ALA ALA VAL SEQRES 7 A 280 LYS TRP ALA LYS ALA ILE PRO GLY PHE ARG ASN LEU HIS SEQRES 8 A 280 LEU ASP ASP GLN MET THR LEU LEU GLN TYR SER TRP MET SEQRES 9 A 280 SER LEU MET ALA PHE ALA LEU GLY TRP ARG SER TYR ARG SEQRES 10 A 280 GLN SER SER ALA ASN LEU LEU CYS PHE ALA PRO ASP LEU SEQRES 11 A 280 ILE ILE ASN GLU GLN ARG MET THR LEU PRO ASP MET TYR SEQRES 12 A 280 ASP GLN CYS LYS HIS MET LEU TYR VAL SER SER GLU LEU SEQRES 13 A 280 HIS ARG LEU GLN VAL SER TYR GLU GLU TYR LEU CYS MET SEQRES 14 A 280 LYS THR LEU LEU LEU LEU SER SER VAL PRO LYS ASP GLY SEQRES 15 A 280 LEU LYS SER GLN GLU LEU PHE ASP GLU ILE ARG MET THR SEQRES 16 A 280 TYR ILE LYS GLU LEU GLY LYS ALA ILE VAL LYS ARG GLU SEQRES 17 A 280 GLY ASN SER SER GLN ASN TRP GLN ARG PHE TYR GLN LEU SEQRES 18 A 280 THR LYS LEU LEU ASP SER MET HIS GLU VAL VAL GLU ASN SEQRES 19 A 280 LEU LEU ASN TYR CYS PHE GLN THR PHE LEU ASP LYS THR SEQRES 20 A 280 MET SER ILE GLU PHE PRO GLU MET LEU ALA GLU ILE ILE SEQRES 21 A 280 THR ASN GLN ILE PRO LYS TYR SER ASN GLY ASN ILE LYS SEQRES 22 A 280 LYS LEU LEU PHE HIS GLN LYS SEQRES 1 B 14 LYS GLU ASN ALA LEU LEU ARG TYR LEU LEU ASP LYS ASP SEQRES 2 B 14 ASP HET CPS A1777 36 HET DEX A1778 28 HETNAM CPS 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1- HETNAM 2 CPS PROPANESULFONATE HETNAM DEX DEXAMETHASONE HETSYN CPS CHAPS HETSYN DEX 9A-FLUORO-16BETA-METHYLPREDNISOLONE FORMUL 3 CPS C32 H58 N2 O7 S FORMUL 4 DEX C22 H29 F O5 FORMUL 5 HOH *83(H2 O) HELIX 1 1 THR A 531 ILE A 539 1 9 HELIX 2 2 SER A 555 LYS A 579 1 25 HELIX 3 3 GLY A 583 LEU A 587 5 5 HELIX 4 4 HIS A 588 SER A 616 1 29 HELIX 5 5 GLN A 632 LEU A 636 5 5 HELIX 6 6 ASP A 638 GLN A 657 1 20 HELIX 7 7 SER A 659 LEU A 672 1 14 HELIX 8 8 SER A 682 LYS A 703 1 22 HELIX 9 9 SER A 708 ASP A 742 1 35 HELIX 10 10 LYS A 743 SER A 746 5 4 HELIX 11 11 PRO A 750 ASN A 766 1 17 HELIX 12 12 ASN B 742 LYS B 751 1 10 SHEET 1 AA 2 LEU A 621 ALA A 624 0 SHEET 2 AA 2 LEU A 627 ILE A 629 -1 O LEU A 627 N PHE A 623 SHEET 1 AB 2 SER A 674 VAL A 675 0 SHEET 2 AB 2 LYS A 770 LYS A 771 -1 O LYS A 770 N VAL A 675 CISPEP 1 GLU A 705 GLY A 706 0 -1.43 CISPEP 2 ASN A 707 SER A 708 0 -1.29 SITE 1 AC1 8 TRP A 557 TRP A 610 ASP A 638 TYR A 660 SITE 2 AC1 8 TYR A 735 GLN A 738 MET A 745 GLN A 776 SITE 1 AC2 14 MET A 560 LEU A 563 ASN A 564 GLY A 567 SITE 2 AC2 14 GLN A 570 MET A 604 ARG A 611 PHE A 623 SITE 3 AC2 14 GLN A 642 TYR A 735 CYS A 736 THR A 739 SITE 4 AC2 14 ILE A 747 PHE A 749 CRYST1 84.660 84.660 105.910 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011812 0.006820 0.000000 0.00000 SCALE2 0.000000 0.013639 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009442 0.00000